12228753

Source:http://linkedlifedata.com/resource/pubmed/id/12228753

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0153594, umls-concept:C0449438, umls-concept:C0521116, umls-concept:C1112682
pubmed:issue	4
pubmed:dateCreated	2002-9-13
pubmed:abstractText	Historically, retroperitoneal lymph node dissection (RPLND) has been used in the therapy of both low-stage and high-stage testicular cancer after chemotherapy. As other therapies have developed, the role of RPLND has also evolved.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9438457
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	1073-2748
pubmed:author	pubmed-author:BihrleRichardR, pubmed-author:FosterRichardR
pubmed:issnType	Print
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	277-83
pubmed:dateRevised	2005-11-16
pubmed:meshHeading	pubmed-meshheading:12228753-Humans, pubmed-meshheading:12228753-Lymph Node Excision, pubmed-meshheading:12228753-Male, pubmed-meshheading:12228753-Neoplasm Staging, pubmed-meshheading:12228753-Retroperitoneal Space, pubmed-meshheading:12228753-Testicular Neoplasms
pubmed:articleTitle	Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate.
pubmed:affiliation	Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. rsfoster@iupui.edu
pubmed:publicationType	Journal Article, Review